Pendulum is the best-known name in Akkermansia probiotics, and its GLP-1 Probiotic is the product most people in this category have heard of. The most striking thing about it is not a claim — it is a disclaimer. Pendulum states plainly that the product is "not intended for weight loss" and "not a GLP-1 agonist drug." In a category built on implying otherwise, that matters.
Product Overview
Pendulum GLP-1 Probiotic is a three-strain live probiotic marketed around GLP-1 signalling pathways. The strains are Akkermansia muciniphila, Clostridium butyricum, and Bifidobacterium infantis — the same combination CoreAge Rx uses in its GLP-1 Support capsule, and closely comparable to Codeage's GLP-1 Probiotic+.
Pendulum as a company has a stronger scientific posture than most supplement brands: it publishes research, works with named strains, and has run clinical work on other products in its range. That context is worth knowing, but it should not be transferred wholesale to this specific product, for which the company cites preclinical studies.
Label, Ingredients, and Amounts
| Active ingredient | Amount per serving |
|---|---|
| Akkermansia muciniphila | Not stated — no per-strain amount or CFU count published on the page |
| Clostridium butyricum | Not stated |
| Bifidobacterium infantis | Not stated |
| Manufacturer | Pendulum |
|---|---|
| Serving size | Not stated on the product page |
| Servings per container | Not stated on the product page |
| Other ingredients | Not stated on the product page |
| Intended use | Marketed to support natural GLP-1 signalling pathways and to help with appetite regulation and craving control |
| Directions | Not stated on the product page |
| Warnings | Not stated on the product page beyond the disclaimers that the product is "not intended for weight loss" and "not a GLP-1 agonist drug" |
| Allergens | Not stated on the product page |
| Pricing | Not published on the GLP-1 Probiotic product page. Pendulum products vary widely — its Akkermansia product is listed at $116 on its own site and around $64 via Amazon |
| Subscription options | Membership and subscription options are referenced across the Pendulum range; terms are not stated on this product page. A 30% referral discount was advertised at the time of review |
| Refund policy | Not stated on the product page |
| Shipping | Not stated on the product page |
How the Manufacturer Says It Works
Pendulum's published explanation is that the strains generate postbiotics — it names propionate, butyrate, and a compound it calls p9 — which in turn support GLP-1 signalling pathways. The marketing positions this as helping quiet snacking urges and support mindful eating.
The headline consumer figures are that 91% reported reduced overall food cravings and 88% reported fewer sugar cravings.
Read the source of those numbers carefully. Pendulum attributes them to a 6-week consumer survey. A survey of customers is not a clinical trial: there is no control group, no blinding, and no objective measurement. People who bought a product and chose to respond to a survey about it are not a neutral sample. These figures describe perception, not a measured effect.
Available Scientific Support
The mechanistic story here is real science. Short-chain fatty acids produced by colonic fermentation — including butyrate and propionate — do influence gut hormone secretion, and GLP-1 release is part of that picture. Clostridium butyricum is a butyrate producer, so the butyrate claim is mechanistically coherent.
Akkermansia muciniphila is the ingredient with the most interesting human data. A proof-of-concept study published in Nature Medicine in 2019 gave pasteurized A. muciniphila to approximately 32 overweight and obese volunteers over three months and reported improvements in insulin sensitivity and several metabolic markers. That is a genuine finding in a serious journal.
Pendulum as a company also has more scientific infrastructure than the typical supplement brand, including published clinical work on other products in its range.
Limitations of the Evidence
- No clinical trial of this product. Pendulum cites preclinical studies for GLP-1 Probiotic. Clinical work on a different formulation in the range does not transfer to this one.
- The headline numbers are survey data. 91% and 88% come from a 6-week consumer survey, not a controlled trial.
- The Akkermansia trial is a pilot. Roughly 32 participants over three months, described by its authors as exploratory. It supports further research rather than confident conclusions.
- No amounts or CFU counts published. Without them you cannot compare the dose to anything in the literature.
- Metabolic markers are not weight loss. Improved insulin sensitivity in a small study is a different claim, and Pendulum correctly does not make the larger one.
Pros and Cons
Pros
- States explicitly that the product is "not intended for weight loss" and "not a GLP-1 agonist drug"
- Contains Akkermansia muciniphila, the ingredient with the most interesting human research in this category
- Names its strains rather than hiding behind a generic "probiotic blend"
- Company has more scientific infrastructure than typical supplement brands, including published research
- Mechanistic story is coherent — C. butyricum is a genuine butyrate producer
- Best-known brand in the Akkermansia category, with corresponding availability
Cons
- No pricing published on the product page
- No serving size, servings per container, CFU counts or per-strain amounts published
- Headline craving figures come from a consumer survey, not a trial
- No clinical trial of this specific product — only preclinical studies cited
- No directions, warnings, or allergen statement on the product page
- No refund policy or shipping terms published
- Pendulum products are expensive relative to comparable formulas from other brands
Who It May Be Best For
This suits someone who wants Akkermansia muciniphila from the most established brand in that niche and is comfortable paying a premium for it. Pendulum's scientific posture is genuinely better than most of the supplement industry, and its willingness to state what the product is not is a meaningful mark of good faith.
It also suits someone approaching this as a gut health decision rather than a weight decision. Framed that way — support the gut environment, see how you feel — the product is being used as its manufacturer describes it.
Who Should Avoid It
- Anyone severely immunocompromised, with an active C. difficile infection, recent IV antibiotics, or a central venous catheter — live bacterial products carry documented infection risk in these groups.
- Pregnant or breastfeeding people, and anyone under 18, without medical advice.
- Anyone expecting appetite suppression comparable to a GLP-1 medication. Pendulum itself says the product is not that.
- Anyone who needs published pricing and terms before buying — neither is on the product page.
- Anyone taking prescription medication or managing a medical condition, without checking with a clinician or pharmacist first.
Alternatives
- Same strain concept, roughly half the observed price: Codeage GLP-1 Probiotic+, which also publishes an AFU count.
- Same strains with published fiber amounts and pricing: CoreAge Rx GLP-1 Support.
- Want a dose that matches published research: NOW Foods Glucomannan for gram-scale fiber.
- Want the actual medication: see our GLP-1 provider rankings.
Frequently Asked Questions
Where does the "91% reduced cravings" figure come from?
Pendulum attributes it to a 6-week consumer survey, alongside a figure of 88% reporting fewer sugar cravings. A consumer survey is not a clinical trial — there is no control group, no blinding, and the results are self-reported by people who chose to buy and take the product. Those numbers describe customer perception rather than a measured effect.
Is Pendulum GLP-1 Probiotic a GLP-1 drug?
No, and Pendulum says so directly. Its own materials state the product is "not a GLP-1 agonist drug" and "not intended for weight loss." We consider that among the most useful things on the page, and it is more restraint than much of this category shows.
What strains does it contain?
Akkermansia muciniphila, Clostridium butyricum, and Bifidobacterium infantis. That is the same three-strain family used by CoreAge Rx GLP-1 Support and, with slight variation, by Codeage GLP-1 Probiotic+.
Has this specific product been tested in a clinical trial?
Not that we could find. Pendulum references preclinical studies for this product. The company has published clinical research on a different product in its range, but evidence for one formulation does not transfer to another.
How much does it cost?
Pricing is not published on the GLP-1 Probiotic product page we reviewed. Pendulum products vary widely — its Akkermansia product is listed at $116 on its own site and around $64 through Amazon. Check the current price and any subscription terms before ordering.
Supplement Disclaimer & Review Date
These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Dietary supplements are not FDA-approved medications, are not reviewed by the FDA for safety or effectiveness before they go on sale, and are not a substitute for prescription treatment.
Nothing on this page is medical advice, and nothing here should be read as a promise of weight loss or of any particular result. Supplements can interact with prescription medications and are not appropriate for everyone. Talk to a doctor or pharmacist who knows your medical history before starting any supplement — particularly if you are pregnant or breastfeeding, take prescription medication, manage a chronic condition, or are already taking a GLP-1 medication.
Details about Pendulum GLP-1 Probiotic come from the manufacturer's own published materials as of the date below. Ingredients, amounts, pricing, and policies change frequently — check the current label and product page before purchasing.
Last reviewed: August 5, 2026
Check the Current Label
Ingredients, amounts, pricing, and policies change. Verify against the current product page before buying.